| Financial Year |
March 31 2023 |
| Monetary Funds |
534,903,647.60 |
| Held-for-trading Financial Assets |
799,650,379.65 |
| Notes Receivable |
489,151,675.00 |
| Accounts Receivable |
343,271,775.53 |
| Advances to Suppliers |
7,669,607.84 |
| Other Receivables |
952,570.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,595,984,494.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
124,187,240.50 |
| Total Current Assets |
3,895,771,391.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
188,868,494.62 |
| Under-construction Projects |
31,723,111.08 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,047,286.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,144,420.58 |
| Deferred Income Tax Assets |
10,379,828.76 |
| Other Non-Current Assets |
8,468,375.68 |
| Sub-Total of Non-Current Assets |
250,331,202.78 |
| Total Assets |
4,146,102,594.36 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
524,457,971.23 |
| Accounts Payable |
667,045,786.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,457,325.21 |
| Taxes Payable |
19,346,188.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
307,352.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
450,812.92 |
| Other Current Liabilities |
48,788,221.75 |
| Sub-Total of Current Liabilities |
1,680,652,881.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,856,383.90 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,085,506.47 |
| Total Liabilities |
1,703,738,388.11 |
| Paid-In Capital(Or Share Stock) |
174,240,000.00 |
| Capital Surplus |
1,528,915,410.36 |
| Surplus Reserve |
61,700,617.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
677,508,178.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,442,364,206.25 |
| Owner's Equity（Stockholder's Equity） |
2,442,364,206.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,146,102,594.36 |
